The PRSS56 gene helps guide eye growth, especially the eye’s length from front to back. If it does not work properly, the eye may stay unusually short, which can lead to strong farsightedness and raise the chance of angle closure glaucoma. Some people with harmful variants in this gene are diagnosed with posterior microphthalmos or nanophthalmos, conditions involving a smaller than usual eye. Many variants are harmless, while a few may change how the gene supports normal eye development.
What is a gene?
Genes are sections of DNA that give cells instructions for making molecules or managing processes throughout the body. Some genes provide the code for proteins, which are the parts of cells that do the work. Others mainly guide when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medications. For a more detailed look at this topic, you can find additional information in the LearnHub.
Overview
PRSS56Gene function
What if the gene works
The PRSS56 gene helps guide normal eye growth, especially the length and shape of the eyeball. This supports clear focus as the eye develops.
Risk
What if the gene does not work
Variants in the PRSS56 gene can lead to unusually small eyes, marked farsightedness, and a higher chance of angle closure glaucoma. Milder to more severe variants may affect how early these eye changes appear and how much vision is affected.
Treatment
What does that mean for your treatment
With a pathogenic or loss-of-function variant in the PRSS56 gene, no PRSS56-specific treatment or drug choice is currently established. Care is guided by the eye findings a person has rather than by the PRSS56 result itself. The PRSS56 gene is being studied as a regulator of eye growth and as a possible drug target for myopia, but this has not reached routine care.
Conditions associated with PRSS56
Gene function
What if the gene works
Clear vision depends on the eye reaching the right shape as it grows. During normal eye development, the PRSS56 gene helps guide eye size and supports the building of key eye tissues. Its protein works outside cells, where it helps coordinate tissue shaping.
During development, the PRSS56 gene helps control how long the eyeball becomes. Keeping eye growth on track helps the retina and lens sit at the right distance for focusing light.
The PRSS56 gene makes a protease (a protein that cuts other proteins) that works outside cells. This protein can help remodel nearby tissue as the eye forms.
The PRSS56 gene also helps organize structures at the front of the eye. These tissues support normal fluid movement and the overall shape of the eye.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, however, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many PRSS56 variants lower or switch off the protein's enzyme activity by changing key building blocks, causing poor folding, or creating a shortened protein that is not released from cells normally. Research on how PRSS56 gene variants affect protein function shows a spectrum: milder changes may leave some activity, while more severe loss-of-function variants can remove it almost completely. This can more strongly disturb eye-growth signaling and may be linked to earlier or more marked PRSS56-related eye features.
How variants are linked to conditions
Pathogenic variants in the PRSS56 gene cause rare inherited eye conditions such as posterior microphthalmia and nanophthalmos, where the eyes are shorter than usual. Many people with these variants are very farsighted and may have a higher chance of angle closure glaucoma. In population studies, some common PRSS56 gene variants have also been linked to differences in eye length and glaucoma risk, but these associations do not mean a person will definitely develop eye disease.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to PRSS56 itself. In families with a disease-causing PRSS56 change, the gene change is usually the main driver, while regular eye checks can still help find problems such as pressure buildup or vision changes early.
Inheritance of PRSS56 variants
For inherited PRSS56-related eye conditions, how PRSS56 gene variants are inherited is usually autosomal recessive. This means a person typically has to inherit two PRSS56 variants, one from each parent, to have the condition, while parents with one variant are often unaffected carriers. When both parents are carriers, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. Because the PRSS56 gene is on chromosome 2, this pattern affects males and females similarly.
What does my PRSS56 result mean for my family?
For PRSS56, the best-known family pattern is recessive, which usually means parents are healthy carriers and brothers or sisters may also be affected or be carriers. Close relatives may want to learn whether the variant runs in the family, especially if there is a history of very small eyes, strong farsightedness, or related vision problems. Children of someone with a PRSS56-related condition are usually carriers unless the other parent also carries a PRSS56 variant.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the PRSS56 gene, clinicians use genetic testing for PRSS56 variants on a blood or saliva sample. A laboratory reads the gene’s DNA code and compares it with the usual sequence to identify changes that may help confirm whether PRSS56 is involved.
When should I consider getting a genetic test?
Consider PRSS56 testing if someone has been found to have very small eyes, severe farsightedness from childhood, or angle-closure glaucoma, especially when it runs in the family. Testing can help confirm whether a change in PRSS56 is the cause and may clarify family risk.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how informative they are depends on the condition and on the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, affect how the body functions. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target, so the same treatment may work better for some people than for others. This is common and can influence how much benefit a person gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can affect how the body processes a drug or how strongly it works. This information can support more informed, more individualized treatment decisions. More about this topic is available in the LearnHub.
Drugs influenced by the PRSS56 gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in guiding medication choice or dose at this time. Questions about your medicines, side effects, or any other health concerns are best discussed with your doctor or pharmacist.
History
In recent decades, awareness of the PRSS56 gene’s role has grown through eye genetics research. Researchers first linked the PRSS56 gene to inherited forms of very small eye size, especially posterior microphthalmia and nanophthalmos, in families where several relatives shared marked farsightedness. From these first observations, research expanded steadily. Later studies showed that certain variants in the PRSS56 gene can also be associated with primary angle closure glaucoma, which broadened medical interest in this gene. As DNA sequencing became more widely used, doctors were able to identify PRSS56-related causes of eye size differences more clearly. These historical steps shaped today’s understanding of PRSS56 as an important gene in inherited eye development.